E-Prescribing Market Trends

  • Report ID: 4611
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

E-Prescribing Market Growth Drivers and Challenges:

Growth Drivers

  • Growing Prevalence of Drug Abuse – It is observed that e-prescriptions can reduce drug abuse among healthcare providers and common citizens. It limits the diversion of drugs and can expose the healthcare providers involved in the drug prescription for non-medical use. Hence, governments of nations are being more active to accelerate the adoption of electronic prescriptions. Therefore, such benefits and rising government initiatives are projected to hike market growth over the forecast period.
  • Statistics show that over 60% of American adults use prescribed medicines, while 3 in 20 teenagers have used a drug without a prescription. Drug abuse has been reported to cost the United States more than $750 billion annually in costs associated with crime, compromised productivity, and healthcare.
  • Medication Errors Caused by Poorly Communicated Prescriptions – On average, over 98000 reported cases of possible medication errors are reported to the FDA in the United States.

  •  Escalation in the Adoption of an Electronic Health Record (EHR) System - It is a patient-centered, real-time record-keeping system that securely and promptly makes information accessible to authorized users. 89.9% of office-based physicians and 86% of non-Federal general acute care hospitals have globally adopted EHR in the last few years.

  • Rising Cases of Incidence of Chronic Diseases - as a result of which, medical institutions are under pressure to efficiently administer and treat the increased prevalence of these conditions. According to the CDC, 12 out of every 20 people in the US have a chronic illness. The prevalence of these conditions is projected to directly aid the expansion of the e-prescribing market in the forecasted period.

Challenges

  • Low Research and Development Investment in Technology in Underdeveloped Countries – resulting in a limited supply of skilled labor caused by low enrolment rates in higher education. Inadequate or unstable policy and regulatory environments capable of promoting progress play a key role in the poor state of science, technology, and innovation in the medical infrastructure of underdeveloped countries.

  • Lack of Network Penetration in Rural Areas
  • High Initial Cost of Installation

Base Year

2025

Forecast Period

2026-2035

CAGR

22.4%

Base Year Market Size (2025)

USD 4.13 billion

Forecast Year Market Size (2035)

USD 31.17 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of e-prescribing is estimated at USD 4.96 billion.

The global e-prescribing market size was more than USD 4.13 billion in 2025 and is anticipated to grow at a CAGR of over 22.4%, reaching USD 31.17 billion revenue by 2035.

North America e-prescribing market is predicted to capture 39.3% share by 2035, driven by increasing utilization of prescribed medication.

Key players in the market include DrChrono Inc., Allscripts Healthcare Solutions, Inc., EPIC Systems, Inc., NextGen Healthcare, Inc., athenahealth, Inc., MCKESSON CORPORATION, Henry Schein One, LLC, DrFirst.com, Inc., Medical Information Technology, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos